Cited by 2,803Cancer-related Molecular PathwaysDNA Repair MechanismsMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., Vogelstein, B.·1998·Science

DOI 10.1126/science.282.5393.1497

Open this paper in CoChat — free account

Abstract

After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.

Integrity signals

Registry

Crossref · 10.1126/science.282.5393.1497

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citation
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Cell Cycle Control and Cancer
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citation
Mitotic and G 2 Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation

Show all 50 references

Research works printed but not linked: 13

Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
Powell S. N., et al., Cancer Res. 55, 1643 (1995);
Fan S., et al., Cancer Res. 55, 1649 (1995);
Russell K. J., et al., ibid. 55, 1639 (1995).
Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
Michieli P., et al., Cancer Res. 54, 3391 (1994);
Paules R. S., et al., Cancer Res 55, 1763 (1995);
Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);

Sorted by citations

Items 701–800 of 1,018

Mechanisms of Diabetes-Induced Endothelial Cell Senescence: Role of Arginase 1
Shosha, E., Xu, Z., Narayanan, S. P., Lemtalsi, T., Fouda, A. Y., Rojas, M., Ji, X., Fulton, D. J., Caldwell, R. W., & Caldwell, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041215 · Cited by 84
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer
van Voss, M. R. H., Vesuna, F., Trumpi, K., Brilliant, J., Berlinicke, C. A., de Leng, W. W. J., Kranenburg, O., Offerhaus, G. J. A., Buerger, H., van der Wall, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4873 · Cited by 84
Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells
Cho, J.-H., Lee, J.-G., Yang, Y., Kim, J., Ahn, J., Baek, N., Lee, K., & Choi, J. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.04.019 · Cited by 85
Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation
Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A., & Lee, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206306 · Cited by 84
New Insights into PARP Inhibitors' Effect on Cell Cycle and Homology-Directed DNA Damage Repair
Jelinic, P., & Levine, D. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0906-t · Cited by 85
Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3
Chaudhary, R., Gryder, B. E., Woods, W. S., Subramanian, M., Jones, M. F., Li, X. L., Jenkins, L. M. M., Shabalina, S. A., Mo, M., Dasso, M., et al. (2017) · eLife · doi:10.7554/elife.23244 · Cited by 86
Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage
Bačević, K., Lossaint, G., Achour, T. N., Georget, V., Fisher, D., & Dulić, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12868-5 · Cited by 91
p53 Activation by Nitric Oxide Involves Down-regulation of Mdm2
Wang, X., Michael, D., de MURCIA, G., & Oren, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112068200 · Cited by 84
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
Tao, Y., Zhang, P., Girdler, F., Frascogna, V., Castedo, M., Bourhis, J., Kroemer, G., & Deutsch, É. (2007) · Oncogene · doi:10.1038/sj.onc.1210990 · Cited by 86
Radiosensitization of lung cancer by nutlin, an inhibitor of murine double minute 2
Cao, C., Shinohara, E. T., Subhawong, T. K., Geng, L., Kim, K. W., Albert, J. M., Hallahan, D. E., & Lü, B. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0356 · Cited by 83
Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer
Camps, J., Nguyen, Q. T., Padilla‐Nash, H. M., Knutsen, T., McNeil, N. E., Wangsa, D., Hummon, A. B., Grade, M., Ried, T., & Difilippantonio, M. J. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20699 · Cited by 83
DNA Damage Is a Prerequisite for p53-Mediated Proteasomal Degradation of HIF-1α in Hypoxic Cells and Downregulation of the Hypoxia Marker Carbonic Anhydrase IX
Kaluzová, M., Kaluz, Š., Lerman, M. I., & Stanbridge, E. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5757-5766.2004 · Cited by 85
Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional
Lossaint, G., Besnard, E., Fisher, D., Piette, J., & Dulić, V (2011) · Oncogene · doi:10.1038/onc.2011.135 · Cited by 83
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis
Ryu, H.-W., Shin, D.-H., Lee, D. H., Choi, J., Han, G., Lee, K. Y., & Kwon, S. H. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.033 · Cited by 82
Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity
Hu, Y., Yang, Y., You, Q., Liu, W., Gu, H.-Y., Zhao, L., Zhang, K., Wang, W., Wang, X., & Guo, Q. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.064 · Cited by 82
IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway
Hu, G., & Barnes, B. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804744200 · Cited by 85
Screening for Compounds That Induce Apoptosis of Cancer Cells Grown as Multicellular Spheroids
Herrmann, R., Fayad, W., Schwarz, S., Berndtsson, M., & Linder, S. T. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107310442 · Cited by 84
Aloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells
Zhang, L., ZHENG, Y., Deng, H., Liang, L., & Peng, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1718 · Cited by 81
Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
Lee, H.-R., Choi, W., Lee, S., Hwang, J., Hwang, E., Guchhait, K., Haas, J., Tóth, Z., Jeon, Y. H., Oh, T.-K., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2142 · Cited by 82
3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation
Jin, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0985-0 · Cited by 82
Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress
Brandl, A., Wagner, T., Uhlig, K. M., Knauer, S. K., Stauber, R. H., Melchior, F., Schneider, G., Heinzel, T., & Krämer, O. H. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs013 · Cited by 83
Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells
Jänicke, R. U., Engels, I. H., Dunkern, T. R., Kaina, B., Schulze‐Osthoff, K., & Porter, A. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204659 · Cited by 81
RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition
Benitez‐Guijarro, M., Lopez‐Ruiz, C., Tarnauskaitė, Ž., Murina, O., Mohammad, M. M., Williams, T., Fluteau, A., Sánchez, L., Vilar‐Astasio, R., García-Cañadas, M., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798506 · Cited by 90
Killer/DR5, A Novel DNA-Damage Inducible Death Receptor Gene, Links the p53-Tumor Suppressor to Caspase Activation and Apoptotic Death
Wu, G. S., Kim, K., & El‐Deiry, W. S. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_13 · Cited by 84
Transgenic livestock: premises and promises
Niemann, H. J., & Kues, W. A. (2000) · Animal Reproduction Science · doi:10.1016/s0378-4320(00)00091-9 · Cited by 81
p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells
Martinez, L. A., Yang, J., Vazquez, E. S., Rodriguez-Vargas, M. D. C., Olivé, M., Hsieh, J., Logothetis, C. J., & Navone, N. M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1289 · Cited by 81
Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
Hiraki, M., Hwang, S.-Y., Cao, S., Ramadhar, T. R., Byun, S., Yoon, K. W., Lee, J. H., Chu, K., Gurkar, A. U., Kolev, V., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.016 · Cited by 81
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
Laranjeira, A. B. A., Hollingshead, M. G., Nguyen, D., Kinders, R. J., Doroshow, J. H., & Yang, S. X. (2023) · Scientific Reports · doi:10.1038/s41598-023-32509-4 · Cited by 80
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner
Lodygin, D., Menssen, A., & Hermeking, H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16588 · Cited by 80
SMIFH2 has effects on Formins and p53 that perturb the cell cytoskeleton
Isogai, T., van der Kammen, R., & Innocenti, M. (2015) · Scientific Reports · doi:10.1038/srep09802 · Cited by 83
Aflatoxin genotoxicity is associated with a defective DNA damage response bypassing p53 activation
Gürsoy-Yüzügüllü, Ö., Yuzugullu, H., Yilmaz, M., & Öztürk, M. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02474.x · Cited by 81
Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines
Knutsen, T., Padilla‐Nash, H. M., Wangsa, D., Barenboim‐Stapleton, L., Camps, J., McNeil, N. E., Difilippantonio, M. J., & Ghadimi, Β. M. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20730 · Cited by 80
Hemizygous Disruption of Cdc25A Inhibits Cellular Transformation and Mammary Tumorigenesis in Mice
Ray, D., Terao, Y., Nimbalkar, D., Hirai, H., Osmundson, E. C., Zou, X., Franks, R. R., Christov, K. T., & Kiyokawa, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4815 · Cited by 80
Direct interaction with and activation of p53 by SMAR1 retards cell‐cycle progression at G2/M phase and delays tumor growth in mice
Kaul, R., Mukherjee, S., Ahmed, F., Bhat, M. K., Chhipa, R., Galande, S., & Chattopadhyay, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.10881 · Cited by 80
Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53
Zhang, C., Gao, C., Kawauchi, J., Hashimoto, Y., Tsuchida, N., & Kitajima, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02382-3 · Cited by 81
5-ASA Affects Cell Cycle Progression in Colorectal Cells by Reversibly Activating a Replication Checkpoint
Luciani, M. G., Campregher, C., Fortune, J. M., Kunkel, T. A., & Gasché, C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.016 · Cited by 80
Epidermal stem cells are resistant to cellular aging
Stern, M. M., & Bickenbach, J. R. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00318.x · Cited by 79
The G2 DNA Damage Checkpoint Delays Expression of Genes Encoding Mitotic Regulators
Crawford, D. F., & Piwnica-Worms, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103414200 · Cited by 79
RASSF7 Is a Member of a New Family of RAS Association Domain–containing Proteins and Is Required for Completing Mitosis
Sherwood, V., Manbodh, R., Sheppard, C., & Chalmers, A. D. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0652 · Cited by 80
GlutathioneS-Transferase π1 Promotes Tumorigenicity in HCT116 Human Colon Cancer Cells
Dang, D. T., Chen, F., Kohli, M., Rago, C., Cummins, J. M., & Dang, L. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1930 · Cited by 80
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175
Hayward, R. L., Schornagel, Q. C., Tente, R., Macpherson, J. S., Aird, R. E., Guichard, S. M., Habtemariam, A., Sadler, P. J., & Jodrell, D. I. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0932-9 · Cited by 79
Cyclotherapy: Protection of Normal Cells and Unshielding of Cancer Cells
Blagosklonny, M. V., & Darżynkiewicz, Z. (2002) · Cell Cycle · doi:10.4161/cc.1.6.259 · Cited by 79
Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway
Meng, L. H., Sefah, K., O’Donoghue, M. B., Zhu, G., Shangguan, D., Noorali, A., Chen, Y., Zhou, L. J., & Tan, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014018 · Cited by 79
Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner
Watson, J. L., Hill, R., Lee, P. W. K., Giacomantonio, C. A., & Hoskin, D. W. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.02.002 · Cited by 79
p53 and p21 Determine the Sensitivity of Noscapine-Induced Apoptosis in Colon Cancer Cells
Aneja, R., Ghaleb, A. M., Zhou, J., Yang, V. W., & Joshi, H. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4282 · Cited by 79
Caspase Cascade Regulated Mitochondria Mediated Apoptosis in Monocrotophos Exposed PC12 Cells
Kashyap, M. P., Singh, A. K., Siddiqui, M. A., Kumar, V., Tripathi, V., Khanna, V. K., Yadav, S., Jain, S., & Pant, A. B. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100234m · Cited by 79
Control of histone modifications
Davie, J., & Spencer, V. A. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1999)75:32+ · Cited by 146
Cadmium-Induced Changes in Apoptotic Gene Expression Levels and DNA Damage in Mouse Embryos Are Blocked by Zinc
Fernández, E. L.-A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg208 · Cited by 79
p53-Dependent Induction of p21Cip1/WAF1/Sdi1 Protects against Oxygen-Induced Toxicity
Helt, C. E. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.2.214 · Cited by 79
ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage
Luo, Y., Lin, F., & Lin, W.-C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6430-6444.2004 · Cited by 81
p53 Activity Results in DNA Replication Fork Processivity
Klusmann, I., Rodewald, S., Müller, L., Friedrich, M., Wienken, M., Li, Y., Schulz‐Heddergott, R., & Dobbelstein, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.036 · Cited by 78
The Role of Caspase-2 in Regulating Cell Fate
Vigneswara, V., & Ahmed, Z. (2020) · Cells · doi:10.3390/cells9051259 · Cited by 87
Programmed cell death, redox imbalance, and cancer therapeutics
Dai, X., Wang, D., & Zhang, J. (2021) · APOPTOSIS · doi:10.1007/s10495-021-01682-0 · Cited by 78
The NUCKS1-SKP2-p21/p27 axis controls S phase entry
Hume, S., Grou, C. P. O., Lascaux, P., D’Angiolella, V., Legrand, A. J., Ramadan, K., & Dianov, G. L. (2021) · Nature Communications · doi:10.1038/s41467-021-27124-8 · Cited by 81
Large T Antigen Promotes JC Virus Replication in G2-arrested Cells by Inducing ATM- and ATR-mediated G2 Checkpoint Signaling
Orba, Y., Suzuki, T., Makino, Y., Kubota, K., Tanaka, S., Kimura, T., & Sawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064311 · Cited by 81
RETRACTED ARTICLE: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
Crociani, O., Zanieri, F., Pillozzi, S., Lastraioli, E., Stefanini, M., Fiore, A., Fortunato, A., D’Amico, M., Masselli, M., Lorenzo, E. D., et al. (2013) · Scientific Reports · doi:10.1038/srep03308 · Cited by 80
Retracted
The p53 Pathway Promotes Efficient Mitochondrial DNA Base Excision Repair in Colorectal Cancer Cells
Chen, D., Yu, Z., Zhu, Z., & Lopez, C. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4103 · Cited by 79
p53 Inhibits Angiogenesis by Inducing the Production of Arresten
Assadian, S., El-Assaad, W., Wang, X. Q. D., Gannon, P. O., Barrès, V., Latour, M., Mes‐Masson, A., Fred Saad, C., Sado, Y., Dostie, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2348 · Cited by 81
Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer
Faraji, F., Zaidi, M. A., Fakhry, C., & Gaykalova, D. A. (2017) · Microbes and Infection · doi:10.1016/j.micinf.2017.06.001 · Cited by 84
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker, K. E., Pica, C. M., Schreiber, R. D., & Piwnica-Worms, D. R. (2001) · PubMed · Cited by 78
Checking Out the Centrosome
Krämer, A., Lukas, J., & Bártek, J. (2004) · Cell Cycle · doi:10.4161/cc.3.11.1252 · Cited by 78
Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage
Gewirtz, D. A. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006414422919 · Cited by 78
MDM2 Integrates Cellular Respiration and Apoptotic Signaling through NDUFS1 and the Mitochondrial Network
Elkholi, R., Abraham‐Enachescu, I., Trotta, A. P., Rubio‐Patiño, C., Mohammed, J. N., Luna‐Vargas, M. P. A., Gelles, J. D., Kaminetsky, J. R., Serasinghe, M. N., Zou, C., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.012 · Cited by 77
p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradation
Broude, E. V., Swift, M. E., Vivo, C., Chang, B.-D., Davis, B. M., Kalurupalle, S., Blagosklonny, M. V., & Roninson, I. B. (2007) · Oncogene · doi:10.1038/sj.onc.1210516 · Cited by 77
High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity
Pierantoni, G. M., Rinaldo, C., Esposito, F., Mottolese, M., Soddu, S., & Fusco, A. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401839 · Cited by 77
Retracted
PINCH-1 Regulates the ERK-Bim Pathway and Contributes to Apoptosis Resistance in Cancer Cells
Chen, K., Tu, Y., Zhang, Y., Blair, H., Zhang, L., & Wu, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707307200 · Cited by 77
Cell Cycle Disturbances and Mitotic Catastrophes in HeLa Hep2 Cells following 2.5 to 10 Gy of Ionizing Radiation
Eriksson, D., Löfroth, P., Johansson, L. F., Riklund, K., & Stigbrand, T. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0980 · Cited by 77
Growth hormone is a cellular senescence target in pituitary and nonpituitary cells
Chesnokova, V., Zhou, C., Ben-Shlomo, A., Zonis, S., Tani, Y., Ren, S.-G., & Melmed, S. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310589110 · Cited by 77
p53-Dependent Regulation of Cdc6 Protein Stability Controls Cellular Proliferation
Duursma, A. M., & Agami, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6937-6947.2005 · Cited by 80
Tumor-associated mutant p53 promotes cancer cell survival upon glutamine deprivation through p21 induction
Tran, T. Q., Lowman, X. H., Reid, M. A., Mendez‐Dorantes, C., Pan, M., Yang, Y., & Kong, M. (2016) · Oncogene · doi:10.1038/onc.2016.360 · Cited by 79
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
Periyasamy, M., Singh, A. K., Gemma, C., Kranjec, C., Farzan, R. A., Leach, D. A., Navaratnam, N., Pálinkás, H. L., Vértessy, B. G., Fenton, T. R., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx721 · Cited by 79
A cautionary tale of sense-antisense gene pairs: independent regulation despite inverse correlation of expression
Goyal, A., Fiškin, E., Gutschner, T., Polycarpou‐Schwarz, M., Groß, M., Neugebauer, J. K., Gandhi, M., Caudron‐Herger, M., Beneš, V., & Diederichs, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx952 · Cited by 77
Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics
Galmarini, C. M., Kamath, K., Vanier-Viornery, A., Hervieu, V., Peiller, E.-L., Falette, N., Puisieux, A., Jordan, M. A., & Dumontet, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600960 · Cited by 80
A quantitative analysis of the kinetics of the G 2 DNA damage checkpoint system
Aguda, B. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11352 · Cited by 77
p53 Localizes to the Centrosomes and Spindles of Mitotic Cells in the Embryonic Chick Epiblast, Human Cell Lines, and a Human Primary Culture: An Immunofluorescence Study
Morris, V. B., Brammall, J., Noble, J. R., & Reddel, R. R. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4800 · Cited by 77
Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging
Jia, G., Su, L., Singhal, S. K., & Liu, X. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1236-8 · Cited by 77
Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer
Jabbour-Leung, N. A., Chen, X., Bui, T. N., Jiang, Y., Yang, D., Vijayaraghavan, S., McArthur, M. J., Hunt, K. K., & Keyomarsi, K. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0519 · Cited by 76
Improved methods for the generation of human gene knockout and knockin cell lines
Topaloglu, Ö. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni160 · Cited by 77
Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells
Luo, L., Werner, K. M., Gollin, S. M., & Saunders, W. S. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.031 · Cited by 76
Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells
Lee, D., Kim, D., Jung, C.-H., Lee, Y. J., & Park, D. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.06.030 · Cited by 76
Mycotoxin Citrinin Induced Cell Cycle G2/M Arrest and Numerical Chromosomal Aberration Associated with Disruption of Microtubule Formation in Human Cells
Chang, C.-H., Yu, F., Wu, T.-S., Wang, L., & Liu, B.-H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq309 · Cited by 76
Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21waf1and p27kip1
Samba‐Louaka, A., Nougayrède, J., Watrin, C., Jubelin, G., Oswald, É., & Taieb, F. E. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01224.x · Cited by 76
Overexpression of c-Myc Alters G 1 /S Arrest following Ionizing Radiation
Sheen, J.-H., & Dickson, R. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1819-1833.2002 · Cited by 76
Pparγ Ligands Inhibit Cholangiocarcinoma Cell Growth Through P53–Dependent Gadd45 and P21Waf1/Cip1 Pathway
Han, C. L., Demetris, J. A., Michalopoulos, G. K., Zhan, Q., Shelhamer, J. H., & Wu, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50296 · Cited by 76
Genetic instability and darwinian selection in tumours
Cahill, D. P., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(99)01874-0 · Cited by 76
Self-citation
Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression
Lindqvist, A., de Bruijn, M., Macurek, L., Brás, A., Mensinga, A., Bruinsma, W., Voets, O., Kranenburg, O., & Medema, R. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.246 · Cited by 75
Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer
Krell, J., Frampton, A. E., Mirnezami, R., Harding, V., de Giorgio, A., Roca-Alonso, L., Cohen, P., Ottaviani, S., Colombo, T., Jacob, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098561 · Cited by 75
Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2
Alshatwi, A. A., Subash‐Babu, P., & Antonisamy, P. (2015) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2015.10.002 · Cited by 80
Global Gene Expression Responses to Low- or High-Dose Radiation in a Human Three-Dimensional Tissue Model
Mezentsev, A., & Amundson, S. A. (2011) · Radiation Research · doi:10.1667/rr2483.1 · Cited by 76
Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development
Breivik, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101137698 · Cited by 75
Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
Origanti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis
Li, X.-H., Chen, X.-J., Ou, W.-B., Zhang, Q., Lv, Z.-R., Zhan, Y., Ma, L., Huang, T., Yan, Y.-B., & Zhou, H.-M. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.003 · Cited by 74
Metabolic response of lung cancer cells to radiation in a paper-based 3D cell culture system
Simon, K. A., Mosadegh, B., Minn, K. T., Lockett, M. R., Mohammady, M. R., Boucher, D. M., Hall, A. B., Hillier, S., Udagawa, T., Eustace, B. K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.002 · Cited by 74
Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D
Kim, T., Oh, S., Shin, S., & Janknecht, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034618 · Cited by 74
BLIMP1 regulates cell growth through repression of p53 transcription
Yan, J., Jiang, J., Lim, C. A., Wu, Q., Ng, H., & Chin, K.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605562104 · Cited by 75
Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest
Don, A. S. A., Dallapiazza, R. F., Bennin, D. A., Brake, T., Cowan, C. E., & Horne, M. C. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.09.023 · Cited by 77
Attenuation of DNA damage‐induced p53 expression by arsenic: A possible mechanism for arsenic co‐carcinogenesis
Shen, S., Lee, J., Weinfeld, M., & Le, X. C. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20406 · Cited by 75
Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways
Weber, H. O., Samuel, T., Rauch, P., & Funk, J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205429 · Cited by 74
Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis
Gogada, R., Amadori, M., Zhang, H., Jones, A., Verone, A. R., Pitarresi, J. R., Jandhyam, S., Prabhu, V. V., Black, J. D., & Chandra, D. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18292 · Cited by 74

Authors: Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
Affiliations: Howard Hughes Medical Institute (US)
F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
Corresponding author: Vogelstein, B.
ORCID: Bunz, F.
Dutriaux, A.
Waldman, T.
Zhou, S.
Brown, J. P.
Sedivy, J. M.
Kinzler, K. W.
Vogelstein, B.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1998-11-20
Volume: 282
Issue: 5393
Pages: 1497-1501
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.282.5393.1497
OpenAlex: W2080125477
Cited by: 2,803
References: 50
Citations by year: 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
FWCI: 41.60
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords: p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
MeSH terms: Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks